Recently, GRK6 inhibitors, GRK6-IN-1 (compound 18) and GRK6-IN-2 (compound 10a), were chemically synthesized and suppressed the cell growth of multiple myeloma cells with a 50% of inhibitory concentration (IC50) at sub-μM [27]. This evidence concerns the gene GRK6 and plasma cell myeloma.